Cancer drugs are the most profitable for Big Pharma
In 2018, cancer drugs earned the pharmaceutical industry $123.8 billion. Soon, they'll be worth billions more. KEVIN DICKINSON 07 February, 2020
A recent report from Evaluate shows oncological therapies were the most profitable in 2018. The report projects cancer drug sales to nearly double by 2024, pocketing a tidy $236.6 billion in profit. These projections come at a time when 42 percent of cancer patients lose their life savings to afford treatment.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.